Skip to main content

Neurogene Inc.

NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404644

In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 2 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Neurogene Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
−7 vs. Q4 2022
Shares held
15.1M
−1.96M (−11.5%) vs. Q4 2022
Total value
$10.5M
+$1.88M (+21.7%) vs. Q4 2022
New holders
4
5 more added
Sold out
11
16 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 39 institutions
Q1 2021: 82 institutionsQ2 2021: 82 institutionsQ3 2021: 85 institutionsQ4 2021: 80 institutionsQ1 2022: 81 institutionsQ2 2022: 64 institutionsQ3 2022: 52 institutionsQ4 2022: 46 institutionsQ1 2023: 39 institutionsQ2 2023: 36 institutionsQ3 2023: 31 institutionsQ4 2023: 35 institutionsQ1 2024: 60 institutionsQ2 2024: 66 institutionsQ3 2024: 86 institutionsQ4 2024: 89 institutionsQ1 2025: 86 institutionsQ2 2025: 83 institutionsQ3 2025: 88 institutionsQ4 2025: 93 institutionsQ1 2026: 96 institutionsQ2 2026: 111 institutions
Value heldQ1 2023: $10.5M
Q1 2021: $341.9MQ2 2021: $248.8MQ3 2021: $187.1MQ4 2021: $118.8MQ1 2022: $46.3MQ2 2022: $21.4MQ3 2022: $12.0MQ4 2022: $8.66MQ1 2023: $10.5MQ2 2023: $14.3MQ3 2023: $14.4MQ4 2023: $179.0MQ1 2024: $617.3MQ2 2024: $482.7MQ3 2024: $581.1MQ4 2024: $367.8MQ1 2025: $192.8MQ2 2025: $230.1MQ3 2025: $265.2MQ4 2025: $340.4MQ1 2026: $342.0MQ2 2026: $544.4M
Institutions holding NGNE and their total value by quarter
QuarterHoldersValue
Q2 2026111$544.4M
Q1 202696$342.0M
Q4 202593$340.4M
Q3 202588$265.2M
Q2 202583$230.1M
Q1 202586$192.8M
Q4 202489$367.8M
Q3 202486$581.1M
Q2 202466$482.7M
Q1 202460$617.3M
Q4 202335$179.0M
Q3 202331$14.4M
Q2 202336$14.3M
Q1 202339$10.5M
Q4 202246$8.66M
Q3 202252$12.0M
Q2 202264$21.4M
Q1 202281$46.3M
Q4 202180$118.8M
Q3 202185$187.1M
Q2 202182$248.8M
Q1 202182$341.9M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q4 2022.

Institutions holding NGNE in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Baker Bros. Advisors LP3,821,740$2.68M0.01%00.0%Unchanged
Lynx1 Capital Management LP2,428,323$1.70M1.42%+137,190+6.0%Added
Redmile Group, LLC1,847,600$1.29M0.06%−2,966−0.2%Reduced
Bank of America Corp1,156,845$809.8K0.00%−467,048−28.8%Reduced
Vanguard Group Inc1,016,296$711.4K0.00%00.0%Unchanged
Renaissance Technologies LLC914,613$640.0K0.00%−278,834−23.4%Reduced
Morgan Stanley821,665$575.2K0.00%+259,242+46.1%Added
Millennium Management LLC777,148$544.0K0.00%−810,119−51.0%Reduced
BlackRock Inc.564,475$395.1K0.00%−49,467−8.1%Reduced
Geode Capital Management, LLC301,057$210.7K0.00%00.0%Unchanged
Two Sigma Advisers, LP234,200$163.9K0.00%−16,100−6.4%Reduced
Two Sigma Investments, LP226,694$158.7K0.00%−72,342−24.2%Reduced
Point72 Asset Management, L.P.136,675$95.7K0.00%00.0%Unchanged
State Street Corp122,556$85.8K0.00%00.0%Unchanged
Kynam Capital Management, LP119,966$84.0K0.01%−798−0.7%Reduced
Privium Fund Management (UK) Ltd117,200$80.3K0.06%00.0%Unchanged
Bridgeway Capital Management, LLC75,000$52.5K0.00%00.0%Unchanged
Northern Trust Corp69,765$48.8K0.00%00.0%Unchanged
HighTower Advisors, LLC48,409$34.0K0.00%00.0%Unchanged
US Bancorp44,346$31.0K0.00%+23,346+111.2%Added
MYDA Advisors LLC40,000$28.0K0.01%+40,000New
BML Capital Management, LLC23,749$16.6K0.01%+23,749New
Simon Quick Advisors, LLC23,428$16.4K0.00%−23,428−50.0%Reduced
Janney Montgomery Scott LLC20,000$14.0K0.00%00.0%Unchanged
Endurance Wealth Management, Inc.20,000$14.0K0.00%00.0%Unchanged
Two Sigma Securities, LLC16,991$11.9K0.00%+16,991New
UBS Group AG14,905$10.4K0.00%−6,884−31.6%Reduced
Bank of New York Mellon Corp14,372$10.1K0.00%00.0%Unchanged
Cubist Systematic Strategies, LLC13,441$9.41K0.00%+13,432+149,244.4%Added
PenderFund Capital Management Ltd.6,709$6.00K0.00%+6,709New
Wells Fargo & Company8,233$5.76K0.00%+40.0%Added
Barclays PLC5,290$3.70K0.00%−446,960−98.8%Reduced
Federated Hermes, Inc.1,903$1.33K0.00%−2,604−57.8%Reduced
Advisor Group Holdings, Inc.1,500$1.08K0.00%00.0%Unchanged
Group One Trading, L.P.1,504$1.05K0.00%−497−24.8%Reduced
Truvestments Capital LLC925$6480.00%00.0%Unchanged
JPMorgan Chase & Co223$00.00%−72,744−99.7%Reduced
Tower Research Capital LLC (TRC)622$00.00%−3,140−83.5%Reduced
Royal Bank of Canada203$00.00%−3−1.5%Reduced
Jane Street Group, LLC0$00.00%−60,667−100.0%Sold out
Sio Capital Management, LLC0$00.00%−38,312−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−26,556−100.0%Sold out
Ergoteles LLC0$00.00%−24,037−100.0%Sold out
Acadian Asset Management LLC0$00.00%−21,188−100.0%Sold out
Nomura Holdings Inc0$00.00%−16,246−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−13,341−100.0%Sold out
Bank of Montreal0$00.00%−10,467−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−10,365−100.0%Sold out
Tri Locum Partners LP0$00.00%−10,248−100.0%Sold out
Citigroup Inc0$00.00%−270−100.0%Sold out